申请人:The Scripps Research Institute
公开号:US20170224653A1
公开(公告)日:2017-08-10
A TLR-independent adjuvant compound that corresponds in structure to Formula I, below, or its pharmaceutically acceptable salt is disclosed in
which X, Y, Z, n, R
1
, R
2
, R
3
, R
4
and W are defined within. Also disclosed are a method of its preparation and use, as well as a pharmaceutical composition containing the same.